(Q40795943)

23 September 2017

CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter (English)

1 reference

23 September 2017

1 reference

Beresford GW

1

1 reference

PubMed ID

11429551

23 September 2017

Boss JM

series ordinal

2

1 reference

PubMed ID

11429551

23 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

23 September 2017

1 reference

23 September 2017

2

1 reference

23 September 2017

652-657

1 reference

23 September 2017

7

1 reference

A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes

23 September 2017

1 reference

7 January 2021

The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression.

1 reference

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

7 January 2021

Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y.

1 reference

7 January 2021

Induction of MHC class I expression by the MHC class II transactivator CIITA.

1 reference

7 January 2021

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

1 reference

7 January 2021

Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis

1 reference

7 January 2021

RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency

1 reference

7 January 2021

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

1 reference

7 January 2021

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

1 reference

7 January 2021

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

1 reference

7 January 2021

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

1 reference

7 January 2021

Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells

1 reference

7 January 2021

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

7 January 2021

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

1 reference

7 January 2021

Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)

1 reference

7 January 2021

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

1 reference

7 January 2021

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

1 reference

7 January 2021

Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes

1 reference

7 January 2021

Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator

1 reference

7 January 2021

Formaldehyde cross-linking and immunoprecipitation demonstrate developmental changes in H1 association with transcriptionally active genes

1 reference

7 January 2021

Mapping DNA interaction sites of chromosomal proteins using immunoprecipitation and polymerase chain reaction.

1 reference

7 January 2021

CREB regulates MHC class II expression in a CIITA-dependent manner

1 reference

7 January 2021

Associations and interactions between bare lymphocyte syndrome factors

1 reference

7 January 2021

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

1 reference

7 January 2021

Real time quantitative PCR

1 reference

7 January 2021

Continuous fluorescence monitoring of rapid cycle DNA amplification

1 reference

7 January 2021

Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.

1 reference

7 January 2021

In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome

1 reference

7 January 2021

Transcriptional activators direct histone acetyltransferase complexes to nucleosomes

1 reference

7 January 2021

The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes.

1 reference

7 January 2021

Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo

1 reference

7 January 2021

A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity

1 reference

7 January 2021

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

1 reference

7 January 2021

The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

1 reference

7 January 2021

Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250

1 reference

7 January 2021

Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates

1 reference

7 January 2021

The language of covalent histone modifications

1 reference

7 January 2021

The drosophila MSL complex acetylates histone H4 at lysine 16, a chromatin modification linked to dosage compensation

1 reference

7 January 2021

Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation

1 reference

7 January 2021

In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma

1 reference

7 January 2021

CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo

1 reference

7 January 2021

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

1 reference

7 January 2021

Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes

1 reference

7 January 2021

Phosphorylated CREB binds specifically to the nuclear protein CBP

1 reference

7 January 2021

NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF.

1 reference

7 January 2021

Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets

1 reference

7 January 2021

Two complementation groups account for most cases of inherited MHC class II deficiency

1 reference

7 January 2021

HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome

1 reference

7 January 2021

Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells

1 reference

7 January 2021

Identifiers

DOI

10.1038/89810

1 reference

23 September 2017

1 reference

PubMed ID

11429551